SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories listed on Forbes Asia’s ‘200 Best Under a Billion’ for 2023

11 Aug 2023 Evaluate

Caplin Point Laboratories has been recognized in Forbes Asia's 200 Best Under a Billion list for the year 2023, a compilation that underscores companies' sustained and robust performance across critical benchmarks. Carefully selected from a substantial pool of more than 20,000 publicly traded companies across the Asia-Pacific region, the chosen 200 enterprises showcase annual sales under $1 billion. The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.


Caplin Point Labs. Share Price

2615.00 67.80 (2.66%)
03-Jul-2026 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1905.10
Dr. Reddys Labs. 1369.00
Cipla 1465.10
Zydus Lifesciences 1113.45
Lupin 2446.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: